Nuklearmedizin. Nuclear medicine · 1999
[Radiation exposure of the patient caused by transmission measurement for myocardial perfusion SPECT].
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Seifert H, Chapot C, Schaefer A, Donsch P, Kirsch C M
Аннотация
AIM: The aim was the determination of the radiation exposure to the patient caused by the transmission measurement for myocardial perfusion SPECT.
METHOD AND MATERIAL: Beside the emission measurement (Tc-99m-MIBI, A = 500 MBq) the myocardial perfusion SPECT simultaneously includes a transmission measurement using a Am-241-line source (A = 5550 MBq). During a simulation of the myocardial perfusion SPECT (without Tc-99m-MIBI) dose measurements with thermoluminescent dosimeters were carried out using a thorax phantom.
RESULTS: For an acquisition time of 20 min the absorbed doses amounted to: surface (xyphoid) 30 microGy, heart 25 microGy, lung 14 microGy, second thoracic vertebra 16 microGy, upper anterior mediastinum 16 microGy, liver 0 microGy. An estimation of the ratio of the effective doses caused by the transmission and the emission measurement of 3.6 x 10(-3) and 4.1 mSv, respectively, resulted in a value of 9 x 10(-4).
CONCLUSION: The radiation exposure of the patient caused by the transmission measurement can be neglected, and is therefore not a limiting factor regarding the general application of transmission measurement for clinical myocardial perfusion SPECT.
METHOD AND MATERIAL: Beside the emission measurement (Tc-99m-MIBI, A = 500 MBq) the myocardial perfusion SPECT simultaneously includes a transmission measurement using a Am-241-line source (A = 5550 MBq). During a simulation of the myocardial perfusion SPECT (without Tc-99m-MIBI) dose measurements with thermoluminescent dosimeters were carried out using a thorax phantom.
RESULTS: For an acquisition time of 20 min the absorbed doses amounted to: surface (xyphoid) 30 microGy, heart 25 microGy, lung 14 microGy, second thoracic vertebra 16 microGy, upper anterior mediastinum 16 microGy, liver 0 microGy. An estimation of the ratio of the effective doses caused by the transmission and the emission measurement of 3.6 x 10(-3) and 4.1 mSv, respectively, resulted in a value of 9 x 10(-4).
CONCLUSION: The radiation exposure of the patient caused by the transmission measurement can be neglected, and is therefore not a limiting factor regarding the general application of transmission measurement for clinical myocardial perfusion SPECT.